IL-6/STAT3 Signaling Contributes to Sorafenib Resistance in Hepatocellular Carcinoma Through Targeting Cancer Stem Cells
- Type
- Retraction
- Notice date
- 8/22/2022 0:00
- Journal
- OncoTargets and Therapy
- Publisher
- Taylor and Francis - Dove Press
- Notice DOI
- 10.2147/ott.s386447
- Original paper DOI
- 10.2147/ott.s262089